Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank24
Year-over-Year Change
Year-over-year total asset growth rate
Latest
-19.52%
↓ 154% vs avg
Percentile
P24
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
36.22%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -19.52% |
| Q3 2025 | 37.45% |
| Q2 2025 | 10.23% |
| Q1 2025 | -16.62% |
| Q4 2024 | 199.89% |
| Q3 2024 | 164.39% |
| Q2 2024 | -25.93% |
| Q1 2024 | -13.31% |
| Q4 2023 | -62.57% |
| Q3 2023 | -55.58% |
| Q2 2023 | -30.42% |
| Q1 2023 | -18.45% |
| Q4 2022 | -14.62% |
| Q3 2022 | -15.89% |
| Q2 2022 | 16.79% |
| Q1 2022 | -14.29% |
| Q4 2021 | -13.78% |
| Q3 2021 | 477.41% |
| Q2 2021 | 263.16% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | -100.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | -100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 86.25% |
| Q2 2019 | 0.00% |
| Q1 2019 | -22.50% |
| Q4 2018 | 0.00% |
| Q3 2018 | -19.84% |
| Q2 2018 | 0.00% |
| Q1 2018 | 490.40% |
| Q4 2017 | 0.00% |
| Q3 2017 | 209.33% |
| Q2 2017 | 0.00% |
| Q1 2017 | -35.53% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |